This research was conducted to investigate 1) the bioavailability of pyridoxine-5'-beta-D-glucoside (PN-glucoside) relative to that of pyridoxine (PN) in human subjects, and 2) the competitive effect of PN-glucoside on the metabolism of co-ingested PN. To evaluate PN-glucoside bioavailability, the subjects were administered a single oral dose of either deuterium-labeled ([2H2]) PN (Trial 1) or [2H2] PN-glucoside (Trial 2), and the urinary excretion rates of labeled 4-pyridoxic acid (4PA) were measured. The [2H2]4PA derived from [2H2] PN or [2H2]PN-glucoside was excreted mainly in the first 8 h after the dose. Excretion of [2H2]4PA during the 48-h postdose period indicated that the bioavailability of PN-glucoside was approximately 50% relative to PN, which is consistent with our previous report of 58% bioavailability determined using a different protocol and fewer subjects. To assess the effects of PN-glucoside on PN utilization, the subjects were administered different ratios of nonlabeled PN-glucoside with [2H2]PN in Trials 3 and 4. Comparing Trial 1 with Trials 3 and 4, the quantity of nonlabeled PN-glucoside, as a fraction of total vitamin B-6 administered, ranged from 0 to 40% (on the basis of pyridoxine equivalents), with a constant dose of [2H2]PN in each. In these trials, the rate but not the total extent of the excretion of [2H2]4PA derived from [2H2]PN was inversely related to the proportion of co-ingested nonlabeled PN-glucoside. Thus, antagonistic effects of PN-glucoside on PN metabolism do occur in humans, although the effect is less pronounced than that seen previously in rats. Such interactive effects must be considered in evaluating the net bioavailability of dietary forms of vitamin B-6.
During studies of the nutritional utilization of pyridoxine 5--D-glucoside, a major form of vitamin B6 in plants, we detected two cytosolic -glucosidases in jejunal mucosa. As expected, one was broad specificity -glucosidase that hydrolyzed aryl -D-glycosides but not pyridoxine -D-glucoside. We also found a previously unknown enzyme, designated pyridoxine--D-glucoside hydrolase, that efficiently hydrolyzed pyridoxine -Dglucoside. These were separated and purified as follows: broad specificity -glucosidase 1460-fold and pyridoxine--D-glucoside hydrolase 36,500-fold. Purified pyridoxine--D-glucoside hydrolase did not hydrolyze any of the aryl glycosides tested but did hydrolyze cellobiose and lactose. Pyridoxine--D-glucoside hydrolase exhibited a pH optimum of 5.5 and apparent molecular mass of 130 kDa by SDS-polyacrylamide gel electrophoresis and 160 kDa by nondenaturing gel filtration, in contrast to 60 kDa for native and denatured broad specificity -glucosidase. Glucono-␦-lactone was a strong inhibitor of both enzymes. Ionic and nonionic detergents were inhibitory for each enzyme. Conduritol B epoxide, a potent inhibitor of lysosomal acid -glucosidase, inhibited pyridoxine--D-glucoside hydrolase but not broad specificity -glucosidase, but both were inhibited by the mechanism-based inhibitor 2-deoxy-2-fluoro--D-glucosyl fluoride. Our findings indicate major differences between these two cytosolic -glucosidases. Studies addressing the role of vitamin B6 nutrition in regulating the activity and its consequences regarding pyridoxine glucoside bioavailability are in progress.A naturally occurring glycosylated derivative of vitamin B6, pyridoxine 5Ј--D-glucoside (PNG), 1 was first isolated from rice bran (1). PNG is now known to exist in most fruits, vegetables, and cereal grains, in which it comprises from 5-75% of total vitamin B6 (2, 3). Because of the prevalence of PNG in plantderived foods, its bioavailability as a source of available vitamin B6 is a matter of nutritional concern. The bioavailability of this glycosylated form of vitamin B6, relative to pyridoxine (PN), is ϳ25% in rats (4, 5) and ϳ50% for humans (6, 7), as estimated from urinary excretion of 4-pyridoxic acid after oral administration of isotopically labeled PNG. The rate-limiting phase of PNG utilization in vitamin B6 metabolism is the hydrolysis of the -glycosidic bond in both rats and humans. These findings indicate that the hydrolysis of PNG is a major factor governing its bioavailability.Glucosidases exist widely in nature. The primary -glucosidases in mammalian tissues consist of a lysosomal membranebound acid -glucosidase (EC 3.2.1.45; N-acylsphingosyl--Dglucopyranoside glucohydrolase) which is responsible for the hydrolytic cleavage of glucosphingolipids (for review see Ref. 8), and a cytosolic -glucosidase capable of hydrolyzing a variety of aryl -D-glycosides (for review see Ref. 9). This cytosolic enzyme has been detected in a variety of mammalian tissues and has been designated broad specificity -glucosidase. A...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.